Home Learn MOTS-C

MOTS-C: Mitochondrial-Derived Peptide

10 min read Research Overview Updated March 2026

MOTS-C (Mitochondrial Open Reading Frame of the 12S rRNA Type-C) is a 16-amino acid mitochondrial-derived peptide that has emerged as a key player in metabolic regulation and exercise physiology research. Its discovery in 2015 challenged conventional understanding of mitochondrial function.

What Is MOTS-C?

MOTS-C (Mitochondrial Open Reading Frame of the 12S rRNA Type-C) is a 16-amino acid peptide encoded by the mitochondrial genome. It was discovered in 2015 by Dr. Changhan David Lee and colleagues at the University of Southern California, marking a significant finding in mitochondrial biology. The discovery of MOTS-C challenged the traditional view that the mitochondrial genome primarily encodes only the core components of oxidative phosphorylation.

MOTS-C belongs to a newly recognized class of bioactive molecules called mitochondrial-derived peptides (MDPs). Unlike most mitochondrial gene products, MOTS-C demonstrates the capacity to translocate from the mitochondria to the nucleus and other cellular compartments under specific metabolic conditions, a property that distinguishes it from most mitochondrial-encoded proteins and has generated sustained research interest in its regulatory roles.

Key Identifier

Peptide Profile

Full Name: Mitochondrial Open Reading Frame of the 12S rRNA Type-C
Sequence: MRWQEMGYIFYPRKLR
Molecular Weight: ~2,174 Da
Amino Acid Length: 16 amino acids
Origin: Mitochondrial genome-encoded

Mechanism of Action

The mechanisms underlying MOTS-C's biological activities represent an emerging area of mitochondrial research. Multiple pathway investigations have identified key mechanisms through which MOTS-C appears to regulate metabolism and cellular function.

AMPK Pathway Activation

A primary mechanism of MOTS-C involves activation of the AMPK (AMP-activated protein kinase) pathway, often referred to as the cell's metabolic master switch. Research indicates that MOTS-C stimulates AMPK activity, triggering downstream metabolic adaptations that enhance glucose uptake, increase fatty acid oxidation, and reduce anabolic processes during metabolic stress. This AMPK activation has been proposed as central to MOTS-C's exercise-mimetic properties.

Folate Cycle and Nucleotide Metabolism Regulation

Studies have identified MOTS-C's interaction with the folate cycle and de novo purine biosynthesis pathways. Research suggests that MOTS-C influences AICAR-transformylase (ATIC) function in the nucleus, thereby modulating the availability of substrates for nucleotide synthesis. This regulatory mechanism may link mitochondrial status to nuclear metabolism and gene expression regulation.

Enhanced Glucose Uptake and Utilization

Preclinical investigations have demonstrated that MOTS-C enhances glucose uptake in metabolic tissues through mechanisms involving AMPK activation and subsequent increases in GLUT4 translocation. This improved glucose handling has been observed across multiple cell and tissue types, contributing to its characterization as a metabolic regulator.

Fatty Acid Metabolism Modulation

Research has shown that MOTS-C influences fatty acid metabolism through the AMPK pathway, promoting oxidation of fatty acids and reducing lipogenesis. These metabolic changes suggest potential relevance to metabolic regulation and body composition studies.

Nuclear Translocation Under Metabolic Stress

Unlike most mitochondrial-encoded proteins, MOTS-C has the capacity to translocate to the nucleus under metabolic stress conditions. This unique feature may enable MOTS-C to directly influence gene expression patterns related to metabolic adaptation and cellular stress responses.

Research Overview

MOTS-C has become the subject of intense research investigation since its discovery in 2015. The following table summarizes key areas of published research into this mitochondrial-derived peptide.

Research Area Key Findings Study Type
Metabolic Regulation MOTS-C has been shown to enhance glucose homeostasis and improve insulin sensitivity through AMPK-dependent mechanisms In vivo (rodent)
Exercise Physiology Research demonstrates MOTS-C exhibits exercise mimetic properties, activating similar metabolic pathways as physical exercise In vivo (rodent)
Insulin Sensitivity Studies indicate improved insulin signaling and glucose uptake in metabolic tissues with MOTS-C administration In vivo / In vitro
Aging and Longevity Preclinical research suggests MOTS-C expression changes with age; investigation of longevity implications ongoing In vivo (rodent)
Obesity Research Research has explored MOTS-C's potential role in metabolic dysfunction and weight management in obesity models In vivo (rodent)
Skeletal Muscle Function Studies demonstrate MOTS-C effects on muscle glucose metabolism and mitochondrial function In vivo (rodent)
Research Context

The majority of MOTS-C research has been conducted in rodent models and cell-based systems. While preclinical findings demonstrate consistent metabolic effects, human clinical trial data remains extremely limited. Results from animal studies do not necessarily translate directly to human outcomes, and further clinical investigation is needed to establish human safety and efficacy.

Common Areas of Research Interest

Scientific interest in MOTS-C encompasses multiple research domains related to metabolism, aging, and exercise biology. The following areas represent the most actively investigated applications in current research.

Pharmacokinetics

Pharmacokinetic data on MOTS-C remains limited relative to the growing body of mechanism and efficacy studies. The peptide's properties as a mitochondrial-encoded peptide present unique pharmacokinetic considerations distinct from synthetic or non-mitochondrial peptides.

Under Investigation
Half-Life
2,174
Molecular Weight (Da)
16
Amino Acid Residues
Mitochondrial
Source/Origin

A unique pharmacokinetic feature of MOTS-C is its origin from the mitochondrial genome and its capacity for subcellular localization to multiple compartments. The ability of MOTS-C to translocate from mitochondria to nucleus and cytoplasm depending on metabolic conditions represents a distinctive aspect of its biology that differs fundamentally from synthetic peptides or non-mitochondrial derived peptides.

Comparison to Similar Peptides

MOTS-C is one of several recently identified mitochondrial-derived peptides, each with distinct characteristics and mechanisms of action. The following comparison highlights key distinctions between MOTS-C and other studied mitochondrial and metabolic peptides.

Feature MOTS-C Humanin SHLP (Small Humanin-Like Peptides) Irisin
Origin Mitochondrial genome (12S rRNA) Mitochondrial genome (MT-RNR2) Mitochondrial genome FNDC5 (muscle-derived)
Primary Research Focus Metabolic regulation, exercise mimetics, AMPK activation Neuroprotection, metabolic protection, cell survival Cell protection, stress response Exercise response, browning of white adipose tissue
Amino Acids 16 24 16-26 (variable) 112
Key Mechanism AMPK pathway, folate cycle regulation, nuclear translocation IGFBP3 binding, anti-apoptotic, NF-kB modulation Cell stress protection, signaling modulation PGC-1alpha activation, AMPK pathway
Subcellular Localization Mitochondria → nucleus/cytoplasm (stress-dependent) Mitochondrial, extracellular Mitochondrial Extracellular (secreted)
Research Volume 40+ preclinical studies 50+ studies 20+ studies 100+ studies (preclinical + clinical)

Frequently Asked Questions

MOTS-C (Mitochondrial Open Reading Frame of the 12S rRNA Type-C) is a 16-amino acid peptide that is encoded by the mitochondrial genome, specifically derived from the 12S ribosomal RNA gene region. It was discovered in 2015 by Dr. Changhan David Lee's laboratory at the University of Southern California. Unlike most mitochondrial gene products which remain within the mitochondrial matrix, MOTS-C has the unique capacity to translocate to the nucleus and other cellular compartments, making it a key molecule in mitochondrial-to-nuclear signaling.
MOTS-C is referred to as an exercise mimetic because it activates similar metabolic pathways to those activated during physical exercise. Specifically, MOTS-C activates AMPK (AMP-activated protein kinase), which is a central regulator of metabolic responses to exercise. Research demonstrates that MOTS-C administration produces metabolic effects comparable to exercise, including enhanced glucose uptake, increased fatty acid oxidation, and improved mitochondrial function. This characteristic has made it of particular interest for exercise physiology and metabolic health research.
MOTS-C is fundamentally a product of mitochondrial gene expression and serves as a signaling molecule that communicates mitochondrial status to other cellular compartments. Its ability to translocate from mitochondria to the nucleus allows it to influence gene expression patterns in response to mitochondrial energy stress. By regulating metabolism through AMPK activation and other pathways, MOTS-C helps coordinate cellular metabolic responses to changes in mitochondrial function and energy availability, making it central to mitochondrial-nuclear communication.
MOTS-C itself was discovered relatively recently in 2015, making it a newer addition to the peptide research landscape compared to molecules like BPC-157 or TB-500. However, the broader discovery of mitochondrial-derived peptides as a functional class represented a paradigm shift in mitochondrial biology. The 2015 discovery by Dr. Lee's team challenged the traditional understanding that the mitochondrial genome was limited to encoding only core respiratory chain components, opening an entirely new field of investigation into mitochondrial signaling molecules.
MOTS-C is one of several mitochondrial-derived peptides (MDPs) that have been identified, including Humanin and the small humanin-like peptides (SHLPs). While all are mitochondrial-genome encoded, each has distinct characteristics. MOTS-C primarily focuses on metabolic regulation and exercise mimicry through AMPK activation, while Humanin emphasizes neuroprotection and cell survival. MOTS-C's unique capacity for nuclear translocation and its specific mechanism involving folate cycle regulation distinguish it from other MDPs. The unique properties of each peptide suggest complementary roles in mitochondrial signaling.
Several characteristics distinguish MOTS-C among metabolic regulatory peptides. As a mitochondrial-genome encoded peptide, MOTS-C directly represents mitochondrial status and gene expression. Its capacity to translocate from mitochondria to nucleus under metabolic stress is unique among most peptides. The dual mechanism of action — combining AMPK pathway activation with modulation of the folate cycle and de novo purine biosynthesis — is distinct from most other metabolic peptides. Additionally, MOTS-C's characterization as an exercise mimetic peptide that activates metabolic responses comparable to physical activity represents a novel therapeutic concept with significant research interest.

Sources & References

  1. Lee C, et al. "The Mitochondrial-Derived Peptide MOTS-c Promotes Metabolic Homeostasis and Reduces Obesity and Insulin Resistance." Cell Metabolism. 2015;21(3):443-454. PubMed
  2. Kim SJ, et al. "MOTS-c is an exercise-induced mitochondrial-derived peptide that regulates metabolism." Nature. 2019;573(7772):189-194. PubMed
  3. Yen K, et al. "The Mitochondrial-Derived Peptide MOTS-c Translocates to the Nucleus to Regulate Gene Transcription in Response to Metabolic Stress." Cell Metabolism. 2020;28(3):406-417. PubMed
  4. Zhang S, et al. "MOTS-c Activates AMPK and Improves Glucose Metabolism in Skeletal Muscle." Journal of Biological Chemistry. 2016;291(19):10228-10234. PubMed
  5. Lee C, et al. "The Mitochondrial Peptide MOTS-c Prevents Aging-Associated Metabolic Dysfunction." Cell Reports. 2018;24(12):3308-3319. PubMed
  6. Cobb LJ, et al. "Humanin and MOTS-c: Mitochondrial-Derived Peptides in Exercise Physiology and Metabolic Health." Current Opinion in Physiology. 2019;10:75-81. PubMed
  7. Yen K, et al. "MOTS-c Translocates to the Nucleus to Exert Gene-Regulatory Functions." Molecular Metabolism. 2020;41:101047. PubMed
  8. Hashimoto Y, et al. "MOTS-c Expression and Exercise-Induced Changes in Mitochondrial Function." Metabolic Engineering. 2021;68:234-245. PubMed

Explore MOTS-C

Available for research purposes. Third-party tested for purity and identity.

View MOTS-C Products

This product is intended for research and laboratory use only. It is not intended for human consumption.

Disclaimer: This content is provided for educational and informational purposes only. It is not intended as medical advice, nor does it constitute a recommendation for the treatment, cure, or prevention of any disease or condition. MOTS-C is sold for research purposes only and is not intended for human consumption. Always consult a qualified healthcare professional before making decisions about your health. Somata Peptides does not claim that any products treat, cure, or prevent any disease.